looks like it really varies, but i have a much clearer picture of what o/s has been reported and basically what we hope to beat
this is what these message boards are for; sharing information to help us make intelligent investing decisions, not the bashing/pumping bs
i'm still not clear on when the oxgn trial started; the pr on enrollment being completed is dated april 2013; if we use that as a marker we're at 11mths and counting, so i would think we would need o/s to extend to summer for it to be statistically significant;
big thinks the trial started 2 years ago; i'm just not sure; no offense big
"In the trial, patupilone and liposomal doxorubicin produce the same PFS (3.7 months median) and a comparable OS (13.2 vs 12.7 months)."
OS of 4.7 and 17 months, respectively. In addition, 40% of patients remained progression-free at 6 months.
median PFS of 4.4 months [95% confidence interval (CI) 3.1–5.5 months], and median OS of 10.7 months. A
Dude, the trial enrollment began in March 20111 and completed in April 2013. That means that some first received dosing of the almost 3 years ago. The vast majority of data to determine Overall Survival is already collected we may just be waiting on a few "events" from the last subjects enrolled. Bless these Women and their families for taking part, hopefully they have been saved much morbidity.